Generic companies drooling over on Lyrica’s market
A series of generics are being developed to target the Lyrica’s(pregabalin)patent expiration date for its pain indication. The number of products that were newly approved this year reaches 30 products.
Since tens of products will be added in this speed, they are expected to compete over the ann...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
